Solis Mammography’s Chief Medical Officer and President of Rose Imaging Physicians Group, Dr. Stephen Rose, presented his abstract on Tomosynthesis Impact on Screening Patients 40 to 49 on Sunday, Nov. 27, at the Radiological Society of North America 2016 Scientific Assembly and Annual Meeting in Chicago. Dr. Rose discovered that recall rates, cancer detection and invasive cancer detection for women under the age of 50 were significantly improved with the addition of tomosynthesis (3-D) to mammography. http://www.letlifehappen.com/research-proves-3-d-mammograms-tomosynthesis-increase-early-detection/